Your browser doesn't support javascript.
loading
Design of the Recombinant Influenza Neuraminidase Antigen Is Crucial for Its Biochemical Properties and Protective Efficacy.
Gao, Jin; Klenow, Laura; Parsons, Lisa; Malik, Tahir; Phue, Je-Nie; Gao, Zhizeng; Withers, Stephen G; Cipollo, John; Daniels, Robert; Wan, Hongquan.
Afiliação
  • Gao J; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Klenow L; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Parsons L; Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Malik T; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Phue JN; Facility for Biotechnology Resources, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Gao Z; Department of Chemistry, University of British Columbiagrid.17091.3e, Vancouver, British Columbia, Canada.
  • Withers SG; Department of Chemistry, University of British Columbiagrid.17091.3e, Vancouver, British Columbia, Canada.
  • Cipollo J; Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Daniels R; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
  • Wan H; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.
J Virol ; 95(24): e0116021, 2021 11 23.
Article em En | MEDLINE | ID: mdl-34613807

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Infecções por Orthomyxoviridae / Vírus da Influenza A Subtipo H1N1 / Anticorpos Antivirais / Neuraminidase Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Infecções por Orthomyxoviridae / Vírus da Influenza A Subtipo H1N1 / Anticorpos Antivirais / Neuraminidase Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article